We aimed to assess the impact of omitting aspirin on clinical outcomes in a real‐world collective of patients receiving oral anticoagulation (OAC) therapy who were treated with a current‐generation drug‐eluting… Click to show full abstract
We aimed to assess the impact of omitting aspirin on clinical outcomes in a real‐world collective of patients receiving oral anticoagulation (OAC) therapy who were treated with a current‐generation drug‐eluting stent (DES) or an everolimus‐eluting bioresorbable vascular scaffold (BVS).
               
Click one of the above tabs to view related content.